Chapter 4, Problem 1CS

(1)

Summary Introduction

To determine:

What is the best way for the research nurse to answer this statement?

Case summary:

A patient on the cardiac telemetry unit had serious health conditions. The cardiologists want to observe the trial of a new drug with the patient as experimental purpose. The patient says that he has high hopes for this drug and he read about it on the internet. He says that he cannot wait for more to get better.

(2)

Summary Introduction

To determine:

Should the research nurse continue with getting the consent form signed? Explain your answer.

Case summary:

Physician met with the nurse and his patient to explain the double-blind experimental study involvement in a patient with a new drug. The ultimate purpose of the therapy, drug, and its hazards are well described to the patient. The physician wants the patient to sign the consent form. When the nurse told this to the patient, the patient said that he will sign it and at the same time, he wants to understand about the placebo of the drug.

(3)

Summary Introduction

To determine:

The patient tells the research nurse, "How can I make sure I have the real drug and not the fake drug? I really want to see if it will help my situation." What is the nurse's best response?

Case summary:

Physician met with the nurse and his patient to explain the double-blind experimental study involvement in a patient with a new drug. The ultimate purpose of therapy, drug, and its hazards are well described to the patient. The physician wants the patient to sign the consent form. When the nurse told this to the patient the patient said that he will sign it and at the same time he wants to understand about the placebo of the drug.

(4)

Summary Introduction

To determine:

After a week, the patient tells the research nurse, "I don't see that this drug is helping me. In fact, I feel worse. But I'm afraid to tell the doctor that I want to stop the medicine. What do I do?" What is the nurse's best response?

Case summary:

Physician met with the nurse and his patient to explain the double-blind experimental study involvement in a patient with a new drug. The ultimate purpose of the therapy, drug, and its hazards are well described to the patient. The physician wants the patient to sign the consent form. When the nurse told this to the patient the patient said that he will sign it and at the same time he wants to understand about the placebo of the drug.